Caption Management, LLC Bluebird Bio, Inc. Call Options Transaction History

Caption Management, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$2.79 - $5.03 $139,500 - $251,500	50,000 New	50,000 $164,000
Q3 2021 Nov 12, 2021	SELL	$11.24 - $21.0 $337,200 - $630,000	-30,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.04 - $22.09 $247,148 - $302,633	13,700 Added 84.05%	30,000 $960,000
Q1 2021 May 17, 2021	SELL	$16.59 - $33.89 $227,283 - $464,293	-13,700 Reduced 45.67%	16,300 $490,000
Q3 2020 Nov 16, 2020	BUY	$34.44 - $43.75 $103,320 - $131,250	3,000 Added 11.11%	30,000 $1.62 Million
Q1 2020 May 15, 2020	SELL	$26.16 - $63.5 $627,840 - $1.52 Million	-24,000 Reduced 47.06%	27,000 $1.24 Million
Q4 2019 Feb 13, 2020	BUY	$46.96 - $61.67 $1.22 Million - $1.6 Million	26,000 Added 104.0%	51,000 $4.48 Million
Q1 2019 May 14, 2019	BUY	$64.44 - $104.11 $1.61 Million - $2.6 Million	25,000 New	25,000 $3.93 Million

144

63.2M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $628M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.